Financial reports
NT 10-Q
Notice of late quarterly filing
14 Feb 24
10-Q
2024 Q1
Quarterly report
20 Nov 23
NT 10-Q
Notice of late quarterly filing
14 Nov 23
10-K
2023 FY
Annual report
23 Oct 23
NT 10-K
Notice of late annual filing
28 Sep 23
10-Q
2023 Q3
Quarterly report
19 May 23
NT 10-Q
Notice of late quarterly filing
15 May 23
10-Q
2023 Q2
Quarterly report
28 Feb 23
NT 10-Q
Notice of late quarterly filing
14 Feb 23
Current reports
8-K
Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement
22 Feb 24
8-K
Departure of Directors or Certain Officers
17 Nov 23
8-K
Departure of Directors or Certain Officers
3 Oct 23
8-K
The Healing Company Appoints Biotech Visionaries Dr. Linda Friedland and Dr. Peter Kash as Advisors
7 Sep 23
8-K/A
Financial Statements and Exhibits
25 Aug 23
8-K
Departure of Directors or Certain Officers
31 Jul 23
8-K
Regulation FD Disclosure
27 Jul 23
8-K
The Healing Company Uplists to the OTCQB Venture Market and Secures New Strategic Investors
7 Jul 23
8-K
Departure of Directors or Certain Officers
2 May 23
8-K
Amendments to Articles of Incorporation or Bylaws
26 Apr 23
Registration and prospectus
D
$1.00 mm in equity, sold $250.00 k, 1 investor
27 Oct 23
8-A12G
Registration of securities
10 May 23
D
Indefinite amount in equity, sold $150.00 k, 1 investor
9 Mar 23
D/A
$1.00 mm in equity, sold $1.00 mm, 2 investors
1 Nov 22
D
$1.00 mm in equity, sold $1.00 mm, 2 investors
28 Oct 22
D
$10M in equity, sold $8.09M, 16 investors
16 May 22
D
$175K in equity, sold $125K, 4 investors
20 Oct 21
S-1
IPO registration
6 Aug 08
Proxies
No filings
Ownership
5/A
Demetrios Elias Argyropoulos
17 Nov 23
5
Demetri Argyropoulos
2 Nov 23
5
Steven Bartlett
2 Nov 23
SC 13G
Argyropoulos Demetri
2 Nov 23
SC 13G
Oelmann Anabel
2 Nov 23
3
Steven John Barr
6 Sep 23
3
Ameeth Sankaran
20 Jul 23
3
Steven Bartlett
10 May 23
3
Demetri Argyropoulos
10 May 23
3
Wanja Oberhof
10 May 23